240 related articles for article (PubMed ID: 29494888)
1. In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Mortelé O; Vervliet P; Gys C; Degreef M; Cuykx M; Maudens K; Covaci A; van Nuijs ALN; Lai FY
J Pharm Biomed Anal; 2018 May; 153():158-167. PubMed ID: 29494888
[TBL] [Abstract][Full Text] [Related]
2. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
[TBL] [Abstract][Full Text] [Related]
3. Suspect and non-target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5Cl-THJ-018.
Vervliet P; Mortelé O; Gys C; Degreef M; Lanckmans K; Maudens K; Covaci A; van Nuijs ALN; Lai FY
Drug Test Anal; 2019 Mar; 11(3):479-491. PubMed ID: 30242979
[TBL] [Abstract][Full Text] [Related]
4. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).
Moosmann B; Bisel P; Westphal F; Wilde M; Kempf J; Angerer V; Auwärter V
Drug Test Anal; 2019 Mar; 11(3):541-549. PubMed ID: 30578721
[TBL] [Abstract][Full Text] [Related]
5. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
Paul M; Bleicher S; Guber S; Ippisch J; Polettini A; Schultis W
J Mass Spectrom; 2015 Nov; 50(11):1305-17. PubMed ID: 26505776
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the in vitro and in vivo metabolism of diacetoxyscirpenol in various animal species and human using ultrahigh-performance liquid chromatography-quadrupole/time-of-flight hybrid mass spectrometry.
Yang S; De Boevre M; Zhang H; De Ruyck K; Sun F; Wang Z; Cao X; Shen J; De Saeger S; Zhang S
Anal Bioanal Chem; 2015 Nov; 407(28):8571-83. PubMed ID: 26362158
[TBL] [Abstract][Full Text] [Related]
7. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
[TBL] [Abstract][Full Text] [Related]
8. Suspect and untargeted screening of bisphenol S metabolites produced by in vitro human liver metabolism.
Gys C; Kovačič A; Huber C; Lai FY; Heath E; Covaci A
Toxicol Lett; 2018 Oct; 295():115-123. PubMed ID: 29908846
[TBL] [Abstract][Full Text] [Related]
9. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.
El Balkhi S; Chaslot M; Picard N; Dulaurent S; Delage M; Mathieu O; Saint-Marcoux F
Int J Legal Med; 2017 Jul; 131(4):979-988. PubMed ID: 28160051
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples.
Noble C; Mardal M; Bjerre Holm N; Stybe Johansen S; Linnet K
Drug Test Anal; 2017 Aug; 9(8):1182-1191. PubMed ID: 27935260
[TBL] [Abstract][Full Text] [Related]
11. Looking at flubromazolam metabolism from four different angles: Metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometry.
Wohlfarth A; Vikingsson S; Roman M; Andersson M; Kugelberg FC; Green H; Kronstrand R
Forensic Sci Int; 2017 May; 274():55-63. PubMed ID: 27863836
[TBL] [Abstract][Full Text] [Related]
12. Application of liquid chromatography coupled to data-independent acquisition mass spectrometry for the metabolic profiling of N-ethyl heptedrone.
Mazzarino M; Camuto C; Comunità F; de la Torre X; Stacchini C; Botrè F
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122989. PubMed ID: 34678705
[TBL] [Abstract][Full Text] [Related]
13. In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
Grafinger KE; Stahl K; Wilke A; König S; Weinmann W
Drug Test Anal; 2018 Oct; 10(10):1607-1626. PubMed ID: 29971945
[TBL] [Abstract][Full Text] [Related]
14. Detection of the designer benzodiazepine flunitrazolam in urine and preliminary data on its metabolism.
Ameline A; Richeval C; Gaulier JM; Raul JS; Kintz P
Drug Test Anal; 2019 Feb; 11(2):223-229. PubMed ID: 30109775
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs.
Lai FY; Erratico C; Kinyua J; Mueller JF; Covaci A; van Nuijs AL
J Pharm Biomed Anal; 2015 Oct; 114():355-75. PubMed ID: 26112925
[TBL] [Abstract][Full Text] [Related]
16. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.
Pettersson Bergstrand M; Meyer MR; Beck O; Helander A
Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics.
Moosmann B; Bisel P; Auwärter V
Drug Test Anal; 2014; 6(7-8):757-63. PubMed ID: 24604775
[TBL] [Abstract][Full Text] [Related]
18. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
Steuer AE; Williner E; Staeheli SN; Kraemer T
Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and phase II metabolites, including a novel succinyl conjugate.
Pozo ÓJ; Ibáñez M; Sancho JV; Lahoz-Beneytez J; Farré M; Papaseit E; de la Torre R; Hernández F
Drug Metab Dispos; 2015 Feb; 43(2):248-57. PubMed ID: 25468950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
